German Portal



 About RMP

About themanager


Send to a friend
Broken Link?

Marketing - Pricing


Money-Back Guarantee … and other ways you never thought to sell your drugs Pharmaceutical corporations are facing significant “pressure points” as blockbuster drug launches continue to slow and a number of major patents are due to expire over the next several years, increasingly driving restructuring and downsizing across the industry. Indeed, high prices on new and existing drugs have become a “double-edge sword” with pharma companies needing more money to fund R&D innovation and payers implementing formularies and other incentives to limit drug use and curtail costs in response.

To help pharma companies adapt to the growing demand for cost effectiveness, Thomas Nagle, a Monitor Group partner and specialist in strategic pricing, prescribes three value-based pricing models designed to boost the health of pharma industry while protecting the “well-being of the healthcare systems and the patients it serves.” pdf 2008






If you have questions or comments to our website, do not hesitate to contact us (comments and questions are always welcomed): webmaster2 AT 
Copyright © 2001 Recklies Management Project GmbH
Status: 05. August 2008